Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.

Jain, Mukul

Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation. [electronic resource] - European journal of pharmacology Jan 2019 - 113-120 p. digital

Publication Type: Journal Article

1879-0712

10.1016/j.ejphar.2018.11.023 doi


Anemia--drug therapy
Animals
Down-Regulation
Erythropoiesis--drug effects
Erythropoietin--blood
Female
Hepcidins--blood
Inflammation--complications
Iron--metabolism
Liver--drug effects
Male
Mice, Inbred BALB C
Prolyl-Hydroxylase Inhibitors--pharmacology
Quinolones--pharmacology
Rats, Inbred Lew
Reticulocyte Count